<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.06 Description of Actuarial Memorandum Including an Asset Adequacy Analysis and Regulatory Asset Adequacy Issues Summary. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/31.05/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/31.05/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|31|05|01|.06|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="31|05|01|.06" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/31.05.01.06"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".06 Description of Actuarial Memorandum Including an Asset Adequacy Analysis and Regulatory Asset Adequacy Issues Summary. | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/31.05/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/31.05/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|31" data-search-heading="">
                  <a href="/us/md/exec/comar/31" title="Title 31 MARYLAND INSURANCE ADMINISTRATION">Title 31 MARYLAND INSURANCE ADMINISTRATION</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|31|05" data-search-heading="">
                  <a href="/us/md/exec/comar/31.05" title="Subtitle 05 ASSETS, LIABILITIES, RESERVES, AND INVESTMENTS OF INSURERS">Subtitle 05 ASSETS, LIABILITIES, RESERVES, AND INVESTMENTS OF INSURERS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|31|05|01" data-search-heading="">
                  <a href="/us/md/exec/comar/31.05.01" title="Chapter 01 Annual Actuarial Opinion and Memorandum">Chapter 01 Annual Actuarial Opinion and Memorandum</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|31|05|01|.06" data-search-heading="">
                  <span title=".06 Description of Actuarial Memorandum Including an Asset Adequacy Analysis and Regulatory Asset Adequacy Issues Summary.">.06 Description of Actuarial Memorandum Including an Asset Adequacy Analysis and Regulatory Asset Adequacy Issues Summary.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="31|05|01|.06">
              <div class="tuf-authenticate">
                <h1 class="h__title--small" id="/us/md/exec/comar/31.05.01.06">.06 Description of Actuarial Memorandum Including an Asset Adequacy Analysis and Regulatory Asset Adequacy Issues Summary.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> General.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> In accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-201" title="">Insurance Article, §5-201, Annotated Code of Maryland</a>, the appointed actuary shall prepare a memorandum to the company describing the analysis done in support of the actuary's opinion regarding the reserves. The memorandum shall be made available for examination by the Commissioner upon the Commissioner's request.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> In preparing the memorandum, the appointed actuary may rely on, and include as a part of the actuary's own memorandum, memoranda prepared and signed by other actuaries who are qualified within the meaning of <a class="internal-link " href="/us/md/exec/comar/31.05.01.02#B(7)" title="">Regulation .02B(7) of this chapter</a>, with respect to the areas covered in those memoranda, and so state in their memoranda.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Memoranda.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(3)(a)">(a)</span> If the Commissioner requests a memorandum, the Commissioner may designate a qualified actuary to review the opinion and prepare a supporting memorandum, if:</p>
                <p class="text-indent-4 "><span class="level-num" id="A(3)(a)(i)">(i)</span> No memorandum exists; or</p>
                <p class="text-indent-4 "><span class="level-num" id="A(3)(a)(ii)">(ii)</span> The Commissioner finds that the analysis described in the memorandum fails to meet the standards of the Actuarial Standards Board or the standards and requirements of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(3)(b)">(b)</span> The reasonable and necessary expense of the independent review shall be paid by the company, but the review shall be directed and controlled by the Commissioner.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> Company Data.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(4)(a)">(a)</span> The reviewing actuary has the same status as an examiner for purposes of obtaining data from the company. The work papers and documentation of the reviewing actuary shall be retained by the Commissioner.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(4)(b)">(b)</span> Information provided by the company to the reviewing actuary and included in the work papers:</p>
                <p class="text-indent-4 "><span class="level-num" id="A(4)(b)(i)">(i)</span> Is considered as material provided by the company to the Commissioner; and</p>
                <p class="text-indent-4 "><span class="level-num" id="A(4)(b)(ii)">(ii)</span> Shall be kept confidential to the same extent as is prescribed by law with respect to other material provided by the company to the Commissioner pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=2-209" title="">Insurance Article, §2-209, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(4)(c)">(c)</span> The reviewing actuary may not be an employee of a consulting firm involved with the preparation of any prior memorandum or opinion for the company pursuant to this regulation for the current year or any one of the preceding 3 years.</p>
                <p class="text-indent-2 "><span class="level-num" id="A(5)">(5)</span> Asset Adequacy Issues Summary.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(5)(a)">(a)</span> In accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-201" title="">Insurance Article, §5-201, Annotated Code of Maryland</a>, the appointed actuary shall prepare a regulatory asset adequacy issues summary, the contents of which are specified in <a class="internal-link " href="/us/md/exec/comar/31.05.01.06#D" title="">§D of this regulation</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(5)(b)">(b)</span> The regulatory asset adequacy issues summary shall be submitted not later than March 15 of the year following the year for which a statement of actuarial opinion based on asset adequacy is required.</p>
                <p class="text-indent-3 "><span class="level-num" id="A(5)(c)">(c)</span> The regulatory asset adequacy issues summary shall be kept confidential to the same extent and under the same conditions as the actuarial memorandum.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Details of Memorandum Section Documenting Asset Adequacy Analysis. When an actuarial opinion under <a class="internal-link " href="/us/md/exec/comar/31.05.01.05" title=".05 Statement of Actuarial Opinion Based on an Asset Adequacy Analysis.">Regulation .05 of this chapter</a> is provided, the memorandum shall demonstrate that the analysis has been done in accordance with the standards for asset adequacy analysis referred to in <a class="internal-link " href="/us/md/exec/comar/31.05.01.03#C" title="">Regulation .03C of this chapter</a> and any additional standards under this chapter. It shall specify:</p>
                <p class="text-indent-2 "><span class="level-num" id="B(1)">(1)</span> For reserves:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(a)">(a)</span> Product descriptions including market description, underwriting, and other aspects of a risk profile, and the specific risks the appointed actuary considers significant;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(b)">(b)</span> Source of liability in force;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(c)">(c)</span> Reserve method and basis;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(d)">(d)</span> Investment reserves;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(e)">(e)</span> Reinsurance arrangements;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(f)">(f)</span> Identification of any explicit or implied guarantees made by the general account in support of benefits provided through a separate account or under a separate account policy or contract, and the methods used by the appointed actuary to provide for the guarantees in the asset adequacy analysis; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(1)(g)">(g)</span> Documentation of assumptions to test reserves for the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(i)">(i)</span> Lapse rates (both base and excess);</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(ii)">(ii)</span> Interest crediting rate strategy;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(iii)">(iii)</span> Mortality;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(iv)">(iv)</span> Policyholder dividend strategy;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(v)">(v)</span> Competitor or market interest rate;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(vi)">(vi)</span> Annuitization rates;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(vii)">(vii)</span> Commissions and expenses; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(1)(g)(viii)">(viii)</span> Morbidity;</p>
                <p class="text-indent-2 "><span class="level-num" id="B(2)">(2)</span> For assets:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(a)">(a)</span> Portfolio descriptions, including a risk profile disclosing the quality, distribution, and types of assets;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(b)">(b)</span> Investment and disinvestment assumptions;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(c)">(c)</span> Source of asset data;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(d)">(d)</span> Asset valuation bases; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(e)">(e)</span> Documentation of assumptions made for:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(e)(i)">(i)</span> Default costs;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(e)(ii)">(ii)</span> Bond call function;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(e)(iii)">(iii)</span> Mortgage prepayment function;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(e)(iv)">(iv)</span> Determining market value for assets sold due to disinvestment strategy; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(e)(v)">(v)</span> Determining yield on assets acquired through the investment strategy;</p>
                <p class="text-indent-2 "><span class="level-num" id="B(3)">(3)</span> For the analysis basis:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(a)">(a)</span> Methodology;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(b)">(b)</span> Rationale for inclusion/exclusion of different blocks of business and how pertinent risks were analyzed;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(c)">(c)</span> Rationale for degree of rigor in analyzing different blocks of business, including the level of materiality that was used in determining how rigorously to analyze different blocks of business;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(d)">(d)</span> Criteria for determining asset adequacy, including the precise basis for determining if assets are adequate to cover reserves under moderately adverse conditions or other conditions as specified in relevant actuarial standards of practice; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(3)(e)">(e)</span> Whether the impact of federal income taxes was considered and the treatment of reinsurance in the asset adequacy analysis;</p>
                <p class="text-indent-2 "><span class="level-num" id="B(4)">(4)</span> Summary of material changes in methods, procedures, or assumptions from the prior year's asset adequacy analysis;</p>
                <p class="text-indent-2 "><span class="level-num" id="B(5)">(5)</span> Summary of results; and</p>
                <p class="text-indent-2 "><span class="level-num" id="B(6)">(6)</span> Conclusion or conclusions.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> In §B(1) and (2) of this regulation, the documentation of the assumptions shall be such that an actuary reviewing the actuarial memorandum could form a conclusion as to the reasonableness of the assumptions.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> Details of the Regulatory Asset Adequacy Issues Summary.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> The regulatory asset adequacy issues summary shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(a)">(a)</span> Descriptions of the scenarios tested, including whether those scenarios are stochastic or deterministic, and the sensitivity testing done relative to those scenarios as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="D(1)(a)(i)">(i)</span> If negative ending surplus results under certain tests in the aggregate, the actuary should describe those tests and the amount of additional reserve as of the valuation date which, if held, would eliminate the negative aggregate surplus values; and</p>
                <p class="text-indent-4 "><span class="level-num" id="D(1)(a)(ii)">(ii)</span> Ending surplus values shall be determined by either extending the projection period until the in-force and associated assets and liabilities at the end of the projection period are immaterial or by adjusting the surplus amount at the end of the projection period by an amount that appropriately estimates the value that can reasonably be expected to arise from the assets and liabilities remaining in force;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(b)">(b)</span> The extent to which the appointed actuary uses assumptions in the asset adequacy analysis that are materially different than the assumptions used in the previous asset adequacy analysis;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(c)">(c)</span> The amount of reserves and the identity of the product lines that had been subjected to asset adequacy analysis in the prior opinion but were not subject to analysis for the current opinion;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(d)">(d)</span> Comments on any interim results that may be of significant concern to the appointed actuary, for example, the impact of the insufficiency of assets to support the payment of benefits and expenses and the establishment of statutory reserves during one or more interim periods;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(e)">(e)</span> The methods used by the actuary to recognize the impact of reinsurance on the company's cash flows, including both assets and liabilities, under each of the scenarios tested; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(f)">(f)</span> Whether the actuary has been satisfied that all options whether explicit or embedded, in any asset or liability, including but not limited to those affecting cash flows embedded in fixed income securities, and equity-like features in any investments, have been appropriately considered in the asset adequacy analysis.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> The regulatory asset adequacy issues summary shall contain the name of the company for which the regulatory asset adequacy issues summary is being supplied and shall be signed and dated by the appointed actuary rendering the actuarial opinion.</p>
                <p class="text-indent-1 "><span class="level-num" id="E">E.</span> Conformity to Standards of Practice. The memorandum shall include a statement:</p>
                <p>"Actuarial methods, considerations, and analyses used in the preparation of this memorandum conform to the appropriate Standards of Practice as promulgated by the Actuarial Standards Board, which standards form the basis for this memorandum."</p>
                <p class="text-indent-1 "><span class="level-num" id="F">F.</span> Use of Assets Supporting the Interest Maintenance Reserve and the Asset Valuation Reserve.</p>
                <p class="text-indent-2 "><span class="level-num" id="F(1)">(1)</span> An appropriate allocation of assets in the amount of the interest maintenance reserve (IMR), whether positive or negative, shall be used in any asset adequacy analysis.</p>
                <p class="text-indent-2 "><span class="level-num" id="F(2)">(2)</span> Analysis of risks regarding asset default may include an appropriate allocation of assets supporting the asset valuation reserve (AVR), and these AVR assets may not be applied for any other risks with respect to reserve adequacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="F(3)">(3)</span> Analysis of these AVR assets and other risks may include assets supporting other mandatory or voluntary reserves available to the extent not used for risk analysis and reserve support.</p>
                <p class="text-indent-2 "><span class="level-num" id="F(4)">(4)</span> The amount of the assets used for the AVR shall be disclosed in the Table of Reserves and Liabilities of the opinion and in the memorandum. The method used for selecting particular assets or allocated portions of assets shall be disclosed in the memorandum.</p>
                <p class="text-indent-1 "><span class="level-num" id="G">G.</span> Documentation. The appointed actuary shall retain on file, for at least 7 years, sufficient documentation so that it will be possible to determine:</p>
                <p class="text-indent-2 "><span class="level-num" id="G(1)">(1)</span> The procedures followed;</p>
                <p class="text-indent-2 "><span class="level-num" id="G(2)">(2)</span> The analyses performed;</p>
                <p class="text-indent-2 "><span class="level-num" id="G(3)">(3)</span> The basis for assumptions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="G(4)">(4)</span> The results obtained.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/31.05.01.05" aria-label=".05 Statement of Actuarial Opinion Based on an Asset Adequacy Analysis.">
                <div class="h__ui">Previous</div>
                <span>.05 Statement of Actuarial Opinion Based on an Asset Adequacy Analysis.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/31.05.01.07" aria-label=".07 Annual Filing Requirement.">
                <div class="h__ui">Next</div>
                <span>.07 Annual Filing Requirement.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
